Investigations of Breast Tumors with Fluorine-18-Fluorodeoxyglucose and SPECT

Journal of Nuclear Medicine

Volumn 37, Issue 4-6, 1996, Pages 615-622

  Holle, Lutz H ^a   Trampert, Ludwin ^a   Lung Kurt, Sabine ^a   Villena Heinsen, Carlos E ^a   Püschel, Werner ^a   Schmidt, Sylvia ^a   Oberhausen, Erich ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Breast tumors; Fluorodeoxyglucose; Radionuclide imaging; SPECT; Wholebody acquisition

Indexed keywords

DEOXYGLUCOSE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FLUORINE; FLUORODEOXYGLUCOSE F 18;

ARTICLE; BREAST TUMOR; COMPARATIVE STUDY; FEASIBILITY STUDY; FEMALE; HUMAN; LYMPH NODE METASTASIS; METASTASIS; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; SCINTILLATION CAMERA; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

BREAST NEOPLASMS; DEOXYGLUCOSE; FEASIBILITY STUDIES; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; GAMMA CAMERAS; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM METASTASIS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030119256     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. American Cancer Society. Cancer figures and facts. New York: American Cancer Society; 1990.
2. Jotfy GS. New prognostic indicators in resectabie breast cancer. Anticancer Res 1991;9:1227-1232.
3. Gisvold, Imaging of the breast: techniques and results. Mayo Clin Proc 1990;65:56-66.
4. Hawkins RA, Choi Y, Huang S-C, et al. Quantitating tumor glucose metabolism with FDG and PET. J Nucl Med 1992;33:339-344.
5. 18F]fluoro-2-deoxy-D-glucose. J Comput Assist Tomogr 1993;17:582-589.
6. Warburg O On the origin of cancer cells. Science 1956;123:309-314.
7. Weber G. Enzymology of cancer cells. N Engl J Med 1977;296:541-551.
8. 18F]2-deoxy-2-fluoro-D-glucose. J Nucl Med 1978;19:1154-1161.
9. 18F]2-fluoro-2-deoxy-D-glucose: nontoxic tracer for rapid tumor detection. J Nucl Med 1980;21:670-675.
10. Larson SM, Weiden PL, Grunbaum Z, et al. Positron imaging studies. 11 Characteristics of 2-deoxyglucose uptake in rodent and canine neoplasms: concise communication. J Nucl Med 1981;22:875-879.
11. 18F-2-fluoro-2-deoxy-D-gucose: comparative autoradiography, glucose-6-phosphatase histochemistry and histology of renally implanted sarcoma of the rat. Res Exp Med 1985;185:87-94.
12. Wahl RL, Hutchins GD, Buchsbaum DJ, et al. Fluorine-18-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts. Cancer 1991;67:1544-1550.
13. 18F]-fluoro-2-deoxy-D-glucose in rodents with mammary carcinoma. Radiology 1992;183:643-647.
14. Paul R. Comparison of fluorine-18-2-fluorodeoxyglucose and gallium-67-citrate imaging for detection of lymphoma. J Nucl Med 1987;28:288-292.
15. Rosenfeld SS, Hoffman JM, Coleman RE, et al. Studies of primary central nervous system lymphoma with fluorine-18-fluorodeoxyglucose positron emission tomography. J Nucl Med 1992;33:532-536.
16. Okada J, Yoshikawa K, Imazeki K, et al. The use of FDG-PET in the detection and management of malignant lymphoma: correlation of uptake with prognosis. J Nucl Med 1991;32:686-691.
17. 18F]-fluoro-2-deoxy-D-glucose. Radiology 1992;184: 441-444.
18. Kubota K, Matsuzawa T, Fujiwara T, et al. Differential diagnosis of lung tumor with positron emission tomography: a prospective study. J Nucl Med 1990;31:1927-1933.
19. Nolop KB, Rhodes CG, Brudin LH, et al. Glucose utilization in vivo by human pulmonary neoplasms. Cancer 1987;60:2682-2689.
20. Minn H, Joensuu H, Ahonen A, Klemi P. Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Cancer 1988;61:1776-1781.
21. Haberkorn U, Strauss LG, Reisser C, et al. Glucose uptake, perfusion and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry J Nucl Med 1991;32:1548-1555.
22. 18F]fluoro-D-glucose in liver metastases from colon carcinoma. J Nucl Med 1982; 23:1133-1137
23. Haberkom U, Strauss LG, Dimitrakopoulou A, et al. PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. J Nucl Med 1991;32:1485-1490.
24. 18F-fluorodeoxyglucose [letter]. Lancet 1985;1:50-51.
25. Okazumi S, Isono K, Enomoto, et al. Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment. J Nucl Med 1992;33.333-339.
26. DiChiro G, Hatazawa J, Katz DA, Rizzoli HV, DeMichele DJ. Glucose utilization by intracranial meningeomas as an index of tumor agressivity and probability of recurrence. a PET study. Radiology 1987; 164:521-526
27. Tyler JL, Diksic M, Villemure J-G, et al. Metabolic and hemodynamic evaluation of gliomas using positron emission tomography. J Nucl Med 1987;28:1123-1133
28. Joensuu H, Ahonen A. Imaging of metastases of thyroid carcinoma with fluorine-18-fluorodeoxyglucose. J Nucl Med 1987,28:910-914.
29. Minn H, Soini I. Fluorine-18-fluorodeoxyglucose scintigraphy in diagnosis and follow up of treatment in advanced breast cancer. Eur J Nucl Med 1989;15.61-66.
30. 18F]-fluoro-2-deoxy-D-glucose Radiology 1991;179:765-770.
31. Ichiya Y, Kuwabara Y, Otsuka M, et al. Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography. J Nucl Med 1991;32:1655-1660.
32. Wahl R, Zasadny K, Helvie M, et al. Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation. J Clin Oncol 1993;11:2101-2111.
33. Cochavi S, Goldsmith SJ, Strashun A, Nadelman J. Planar imaging of positron emitting radionuclides with a multicrystal camera. J Nucl Med 1982;23:722-730.
34. 18F-2-deoxy-2-fluoro-D-glucose myocardial tomography using a normal large field of view gamma camera. Angiology 1989;40:1058-1064.
35. vanLingen A, Huijgens PC, Visser FC, et al. Performance characteristics of a 511-keV collimator for imaging positron emitters with standard gamma camera. Eur J Nucl Med 1992;19:315-321.
36. Schaefer A, Oberhausen E. Physical performance of a multispect-two gamma camera for imaging positron emitters. (Testmessungen an der Multispect-2-Gammakamera zum Nachweis von 511 keV-gammastrahlung). Nuklearmedizin 1995;34:40-46.
37. NEMA Standards Publication No. NU 1: Performance characteristics of scintillation cameras. 1986.
38. Dahlbom M, Hoffman EJ, Hoh CK, et al. Whole-body positron emission tomography. Part I. Methods and performance characteristics. J Nucl Med 1992;33:1191-1199.
39. Björntorp P. Sjoströem L. Carbohydrate storage in man. Speculations of some quantitative considerations. Metabolism 1978;27(suppl 2):1853-1863.
40. Thiebaud D, Jacot E, DeFronzo RA, et al. The effect of graded doses of insulin on total glucose uptake, glucose oxidation and glucose storage in man. Diabetes 1982;31:957-963.
41. Wahl RL, Henry C, Ethier S. Serum glucose effects on the tumor and normal tissue uptake of FDG in rodents with breast carcinoma [Abstract]. J Nucl Med 1990;31:888-889.
42. 18F-2-fluoro-2-deoxy-D-glucose. Eur J Nucl Med 1985;10: 341-345.
43. Berry JJ, Baker JA, Pieper KS, et al. The effect of metabolic milieu on cardiac PET imaging using fluorine-18-deoxyglucose an nitrogen-13-ammonia in normal volunteers. J Nucl Med 1991;32:1518-1525.
44. Fidler IJ. The biology of human cancer metastasis. Acta Oncol 1991;30:669-675.
45. Sasaki M, Ichiya Y, Kuwabara et al. Fluonne-18-fluorodeoxyglucose positron emission tomography in technetium-99m-hydroxymethylenediphosphonate negative bone tumore. J Nucl Med 1993;34:288-290.
46. 18F]-fluorodeoxyglucose uptake in abdominal abscesses: a PET study. J Comput Assist Tomogr 1989;13:829-831.
47. Sasaki M, Ichiya Y, Kuwabara Y, et al. Ringlike uptake of [F-18] FDG in brain abscess: a PET study. J Comput Assist Tomogr 1990;14:486-487.
48. Kubota R, Yamada S, Kubota K, et al. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissue studied by microautoradiography. J Nucl Med 1992;33:1972-1980.
49. Kubota R, Kubota K, Yamada S, et al. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglacose uptake. J Nucl Med 1994;35:104-112.
50. Kao CH, Wang SJ, Liu TJ. The use of technetium-99m-metoxyisobutylisonitrile breast szintigraphy to evaluate palpaple breast masses. Eur J Nucl Med 1994;21:432-436.
51. 201TI. Clin Nucl Med 1992;17:171-76.
52. Kaiser WA, Zeitler E. MR imaging of the breast: fast imaging sequences with and without GD DTPA. Radiology 1989;170:681-86.
53. Heywang SH, Wolf A, Prass E, Hubertz T, Eiermann W, Permanetter W. MR imaging of the breast with GD-DTPA: use and limitations. Radiology 1989;171:95-103.